Meridian Bioscience, Inc. Reports First Quarter 2014 Operating Results, Declares Increased Regular Cash Dividend, And Reaffirms Fiscal 2014 Guidance

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Meridian Bioscience, Inc. (NASDAQ: VIVO) today:

•reported first quarter net sales of $44.8 million, a decrease of 1% from the same period of the prior fiscal year;

•reported first quarter operating income of $11.6 million, a decrease of 11% from the same period of the prior fiscal year

Help employers find you! Check out all the jobs and post your resume.

Back to news